May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
PKCbetaII/HuR/VEGF: a New Molecular Cascade in Retinal Pericytes for the Regulation of VEGF Gene Expression
Author Affiliations & Notes
  • F. Drago
    University of Catania, Catania, Italy
    Department of Exp & Clin Pharmacology,
  • C. Bucolo
    University of Catania, Catania, Italy
    Department of Exp & Clin Pharmacology,
  • M. L. Amadio
    Department of Pharmacology, University of Pavia, Pavia, Italy
  • G. Scapagnini
    Department of Health Sciences, University of Molise, Campobasso, Italy
  • G. Lupo
    University of Catania, Catania, Italy
    Department of Biochemistry,
  • S. Govoni
    Department of Pharmacology, University of Pavia, Pavia, Italy
  • A. Pascale
    Department of Pharmacology, University of Pavia, Pavia, Italy
  • Footnotes
    Commercial Relationships  F. Drago, None; C. Bucolo, None; M.L. Amadio, None; G. Scapagnini, None; G. Lupo, None; S. Govoni, None; A. Pascale, None.
  • Footnotes
    Support  PRIN - MUR
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5365. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Drago, C. Bucolo, M. L. Amadio, G. Scapagnini, G. Lupo, S. Govoni, A. Pascale; PKCbetaII/HuR/VEGF: a New Molecular Cascade in Retinal Pericytes for the Regulation of VEGF Gene Expression. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5365. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : VEGF-induced new vessels formation is a key event in diabetic retinopathy, a severe progressive multistage pathology. Literature data indicate that Protein Kinase C (PKC) is involved in the control of VEGF expression, but no data are so far available on the molecular pathway underlying this process. We investigated whether PKCβII could control VEGF expression at posttranslational level via the mRNA stabilizing human embryonic lethal abnormal vision (ELAV)-like protein, HuR.

Methods: : Retinal bovine pericytes were exposed to phorbol esters to activate PKC. The direct interaction/activation of PKCβII with HuR was examined by western blotting, immunoprecipitation and immunocytochemistry. The binding of HuR to VEGF was assessed in ribonucleoproteic complexes by immunoprecipitation coupled with real-time PCR. VEGF was immunoprecipitated from the medium.

Results: : The data show that PKCβII activation is responsible, through the RNA-binding protein HuR, of the increase of VEGF protein content and its release in the medium. The specificity of the PKCβII involvement was confirmed using a selective inhibitor. Following acute high-glucose insult this pathway seemed still functioning, suggesting that a brief pick of glucose does not compromise this molecular cascade in pericytes.

Conclusions: : We suggest the existence of a new molecular cascade, operating in retinal bovine pericytes and involving PKCβII, HuR, and VEGF. A better understanding on this new pathway could open novel opportunities for the development of innovative pharmacological therapies useful in pathologies where VEGF plays a key role such as in diabetic retinopathy.

Keywords: vascular endothelial growth factor • diabetic retinopathy • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×